Individualized dosing strategies for Oncolytic agents and Intoatumoral Pharmacokinetics

Ruben van Eerden

Individualized dosing strategies for Oncolytic agents and Intoatumoral Pharmacokinetics

Ruben van Eerden

Medical Oncology

Research output: Types of Thesis › Doctoral Thesis › Internal

53 Downloads (Pure)

Abstract

In the first part of my thesis, we discuss strategies to personalize the dose of anticancer drugs, for example via the implementation of Therapeutic Drug Monitoring or pharmacogenetic guided dosing. In the second part of my thesis, we focus on the intratumoral pharmacokinetics of different types of chemotherapy and possible strategies to improve the intratumoral exposure to chemotherapy.

Original language	English
Awarding Institution	Erasmus University Rotterdam
Supervisors/Advisors	Mathijssen, Ron, Supervisor Koolen, Stijn, Co-supervisor
Award date	7 Jul 2023
Place of Publication	Rotterdam
Print ISBNs	978-94-6483-176-4
Publication status	Published - 7 Jul 2023

Access to Document

final dissertation Eerden, Ruben vanFinal published version, 78.5 MB
embargo version Eerden, Ruben vanOther version, 74.3 MB

Cite this

@phdthesis{637c052df04f471895ff55dc243f05c3,

title = "Individualized dosing strategies for Oncolytic agents and Intoatumoral Pharmacokinetics",

abstract = "In the first part of my thesis, we discuss strategies to personalize the dose of anticancer drugs, for example via the implementation of Therapeutic Drug Monitoring or pharmacogenetic guided dosing. In the second part of my thesis, we focus on the intratumoral pharmacokinetics of different types of chemotherapy and possible strategies to improve the intratumoral exposure to chemotherapy.",

author = "{van Eerden}, Ruben",

year = "2023",

month = jul,

day = "7",

language = "English",

isbn = "978-94-6483-176-4",

school = "Erasmus University Rotterdam",

}

TY - BOOK

T1 - Individualized dosing strategies for Oncolytic agents and Intoatumoral Pharmacokinetics

AU - van Eerden, Ruben

PY - 2023/7/7

Y1 - 2023/7/7

N2 - In the first part of my thesis, we discuss strategies to personalize the dose of anticancer drugs, for example via the implementation of Therapeutic Drug Monitoring or pharmacogenetic guided dosing. In the second part of my thesis, we focus on the intratumoral pharmacokinetics of different types of chemotherapy and possible strategies to improve the intratumoral exposure to chemotherapy.

AB - In the first part of my thesis, we discuss strategies to personalize the dose of anticancer drugs, for example via the implementation of Therapeutic Drug Monitoring or pharmacogenetic guided dosing. In the second part of my thesis, we focus on the intratumoral pharmacokinetics of different types of chemotherapy and possible strategies to improve the intratumoral exposure to chemotherapy.

M3 - Doctoral Thesis

SN - 978-94-6483-176-4

CY - Rotterdam

ER -

Individualized dosing strategies for Oncolytic agents and Intoatumoral Pharmacokinetics

Abstract

Access to Document

Other files and links

Fingerprint

Cite this